ClinicalTrials.gg
CompletedNCT04928235Updated Dec 7, 2023

Utility of Thermal Imaging in Diagnosis of Cellulitis for Lower Extremity Complaints in the Emergency Department

An observational study in Cellulitis and Skin and Subcutaneous Tissue Infection, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-07.

Sponsored by University of Wisconsin, Madison · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
416
Ages
18 Years and older
Sex
All
01

Study summary

The overall purpose of the study is to determine how providing physicians with a quantitative measure of skin surface temperature influences diagnoses and diagnostic confidence in potential cellulitis cases when added to the standard evaluation.

Read the detailed description

Previous literature estimates the emergency department misdiagnosis rate for cellulitis exceeds 30% due to conditions which can mimic cellulitis (termed pseudocellulitis). These diagnostic errors are associated with an estimated $195 to $515 million dollars in avoidable healthcare spending each year. Objective skin surface temperature measurement, obtained via thermal imaging cameras, has been proposed as a diagnostic adjunct that may reduce diagnostic error in cases of suspected cellulitis. One recent study, identified that the maximum affected skin temperature in cellulitis is significantly higher than in pseudocellulitis, and the temperature gradient between affected and unaffected sites in patients with cellulitis is significantly higher than in patients with pseudocellulitis.

The overall purpose of the study is to determine how providing physicians with a quantifiable measure of skin surface temperature information influences diagnoses and diagnostic confidence in potential cellulitis cases when added to standard physical exam techniques

The Aims of the study are to :

Specific Aim 1: To characterize the temperature difference between affected and unaffected limbs in patients with cellulitis in the emergency department.

Specific Aim 2: To characterize the temperature difference between cases of cellulitis and pseudocellulitis

Specific Aim 3: To determine how quantifying temperature gradients changes diagnostic confidence and accuracy when added to the standard diagnostic evaluation for potential cellulitis.

The investigators will prospectively enroll a maximum of 560 patients with non-traumatic lower extremity dermatologic complaints with visible erythema (potential cellulitis) in the University of Wisconsin Emergency Department. A thermal image and a photograph of the affected and the unaffected limbs will be taken.

02

Conditions studied

  • Cellulitis
  • Skin and Subcutaneous Tissue Infection

Browse trials for

Keywords

  • Diagnostic confidence
  • Diagnostic accuracy
  • Diagnostic error
03

In context

Cellulitis

160 studies on the registry are indexed under Cellulitis; 14 are open to participants now.

This study's enrollment of 416 is above the median of 208 across 29 observational studies indexed under Cellulitis.

Browse Cellulitis studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,188 studies on the registry; 181 are open to participants now.

Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Seeking to include all patients who present to the Emergency Department for a skin related, acute lower extremity complaint and able to provide informed consent.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participant is presenting to the University of Wisconsin Emergency Department
  • Participant has an acute skin complaint on the lower extremity

Exclusion criteria

Exclusion Criteria:

  • Participant is has limited English and Spanish proficiency
  • There was an acute traumatic injury of affected area in last 5 days- includes burns
  • Affected area has a confirmed fracture
  • Participant is pregnant
  • Participant is a prisoner
  • Current complaint is in an area of past surgical procedure (within past 4 weeks)
  • Participant has implant or hardware at site
  • Animal or human bite is cause of complaint
  • Temperature of the leg has been altered in the last one hour
  • Unable to provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
416 participants (actual)
Patient registry
No

Groups and cohorts

  • All Participants

    All participants will have thermal imaging of their lower extremities. The temperature values will be shared with the attending physician. The physician will be asked questions about their diagnostic confidence before and after seeing the temperature values.

    Diagnostic Test: Thermal Imaging as Diagnostic Adjunct

Interventions

  • Diagnostic testThermal Imaging as Diagnostic Adjunct

    Thermal images of the participants lower extremities will be taken and skin surface temperature values will be provided to the healthcare provider for review during the emergency department encounter.

06

What researchers measure

Primary outcomes

  1. Skin Temperature Difference Between Affected and Unaffected Legs for Participants with Cellulitis

    Differences in skin surface temperatures of affected and unaffected areas for those with a final diagnosis of cellulitis.

    Time frame: up to one hour

  2. Skin Temperature Difference Between Participants Diagnosed with Pseudocellulitis and Cellulitis

    Determine differences in skin surface temperatures between cases of pseudocellulitis and cellulitis (on the affected legs).

    Time frame: up to one hour

Secondary outcomes

  1. Change in Diagnostic Confidence as Measured by Physician Self-Report

    Comparison of the change in diagnostic confidence as measured by the attending physician response pre/post thermal imaging review. This was a question developed by the study team and response options include not at all confident, slightly confident, somewhat confident, very confident, extremely confident. No number values are assigned to response values as of yet.

    Time frame: up to one hour

  2. Diagnostic agreement with expert review panel

    Provider cellulitis diagnostic assignment (yes/no) will be compared to an expert panel to determine the rate of concordance.

    Time frame: 6 months

07

Study locations

1 site
  • University of Wisconsin Emergency Department
    Madison, Wisconsin 53705, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04928235
Collaborators
Agency for Healthcare Research and Quality (AHRQ)
Responsible party
Sponsor
First posted
Jun 16, 2021
Start date
Jul 18, 2021
Primary completion
Jan 18, 2023
Completion
Feb 18, 2023
Last update
Dec 7, 2023

Study contacts

Michael Pulia, MD, MS
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion